| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silexion Therapeutics Corp | Chairman and CEO, Director | Ordinary Shares | 65,471 | $159,749 | $2.44 | 20 Feb 2026 | Direct |
| Silexion Therapeutics Corp | Chairman and CEO, Director | Stock Option (right to buy Ordinary Shares) | 956 | $2,332 | $2.44 | 20 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLXN | Silexion Therapeutics Corp | 20 Feb 2026 | 1 | $0 | 4 | Chairman and CEO, Director | 23 Feb 2026, 16:14 |
| SLXN | Biomotion Sciences | 15 Aug 2024 | 0 | $0 | 3 | Chairman and CEO, Director | 15 Aug 2024, 19:48 |